Raiding NIH for the War Department.
The agency that funds pandemic and infectious-disease research signed a deal to hand a chunk of its budget to the Pentagon — quietly, with no dollar figure attached, over the objections of the lawmakers who control the money.
We verified it against Nature, Science, and the lawmakers' own statements — graded what's solid, corrected where the viral version overstates, and carried the NIH director's defense.
What this page is about
In September 2026, reporting from Nature, Science, and others revealed an interagency agreement between the National Institutes of Health and the Department of Defense — which the Trump administration has rebranded the “Department of War” — that would route money out of the NIH's infectious-disease institute, NIAID, to fund biodefense research at the Pentagon. The framework is built to last up to ten years. It was not publicly announced; lawmakers learned of it and objected.
The single strangest thing about it: NIH's own leadership had, earlier in 2026, publicly argued that the agency should drop biodefense and pandemic-preparedness work. Now the same leadership has signed a deal to pay the Pentagon to do that very research — with NIH's money. This page grades what's established, marks where the widely shared summary runs ahead of the record, and gives the NIH director's rebuttal its due.
Books that go deeper on this story. Links are Amazon affiliate searches — buying through them supports the work at no cost to you.
The same investigation, restaged one beat at a time. Step through it here, or present it fullscreen.
Raiding NIH for the War Department.
The agency that funds pandemic and infectious-disease research signed a deal to hand a chunk of its budget to the Pentagon — quietly, with no dollar figure, over the objections of the lawmakers who control the money.
The deal, the money, and the objections
NIH signed an interagency agreement to route infectious-disease money to the Pentagon, framed to last a decade.
FACTMultiple reputable outlets — Nature, Science, Ars Technica, and the University of Minnesota's CIDRAP — reported that NIH and the Department of Defense signed an interagency agreement to move funds from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to military biodefense programs, with a framework running up to ten years. The Trump administration has rebranded the Defense Department the 'Department of War,' the name used in the agency's own posts about the deal.
The money would come from NIAID's $6.6 billion budget — with reported figures ranging up to about $2 billion a year.
FACTCongress allocated NIAID about $6.6 billion for 2026. Reporting on how much could move varies because the agreement itself is vague: Nature described 'hundreds of millions of dollars' worth of projects,' while the widely shared summary cites a ceiling of up to $2 billion a year — which would be roughly a third of NIAID's budget. We grade the source of the money and the reported range as fact, and flag the uncertainty: the exact amount isn't pinned down, and the NIH director says none moves in the current fiscal year.
It was done without a public announcement, and lawmakers who control the money called it a Pentagon money-grab.
FACTThere was no public announcement; members of Congress learned of the agreement and condemned it. Rep. Rosa DeLauro, the top Democrat on House Appropriations, called it a 'secretive attempt to siphon research funds away from NIH' and 'outrageous.' Sen. Patty Murray accused the parties of using the agreement to transfer money to the Pentagon without congressional approval. Some scientists see it as part of a longer-term effort to move biosecurity research out of NIH and into the military.
NIH's own leaders said the agency should drop this research — then signed a deal to pay the Pentagon to do it.
FACTThis is the part that makes it hard to read as ordinary policy. In a commentary earlier in 2026, the heads of NIH and NIAID explicitly argued for dropping biodefense research and pandemic preparedness from the agency's remit, in favor of focusing on 'the most impactful infectious diseases that Americans currently face.' Yet the new agreement directs NIH money to fund exactly that kind of work — 'future pandemic strains, CBRN threats and other emerging infectious disease' — at the Department of Defense. NIH is paying to have done elsewhere the research its leadership said it shouldn't do.
The NIH director's defense: no money moves this year, and it's a partnership, not a siphon.
FACTWe carry NIH Director Jay Bhattacharya's rebuttal in full. He said no funds will go to the Defense Department this fiscal year, which ends September 30, and framed the deal as a research partnership: 'Far from siphoning money away from research, this partnership between NIH and the Department of War focuses on research projects that will drive discoveries to improve the health of American citizens and members of the military.' Readers can weigh that against the secrecy, the vagueness, and the contradiction with his own prior position.
What the viral post gets right — and where it runs ahead
- Right: the secrecy and the direction of travel. A ten-year agreement to move NIAID money to the Pentagon, with no public announcement and no clear dollar figure, drawing bipartisan-appropriator alarm — that's all documented. The core of the post holds.
- Overstated: “sending money” as a done deal. The agreement is a framework, described by reporters as vague, and the NIH director says no funds move this fiscal year. It sets up a diversion; it hasn't executed a $2-billion transfer. The “up to $2 billion” is a reported ceiling, not a confirmed sum.
- The strongest fact isn't in the post at all. The genuine scandal is the contradiction: NIH leadership said pandemic-prep and biodefense weren't NIH's job, then agreed to pay the military to do that research with NIH money. That's the detail that turns a budget maneuver into a story about who controls the science.
- Still live. A future Congress could prohibit this kind of spending, and appropriators have signaled they might. The outcome isn't settled — which is exactly why the lack of transparency matters now.
Draining the disease lab, on the way into flu season
NIAID is the institute behind pandemic-flu preparation and infectious-disease defense — the civilian capacity a country leans on when the next outbreak comes. Quietly routing a slice of its budget to the Pentagon, while the agency's leaders openly say that work isn't their job, is a decision about national priorities made without the public or, arguably, Congress in the room. That is the definition of Looting the American Public: public money and public capacity redirected out of view, and a Military Grift story in the literal sense — the war budget reaching into the disease budget.
It also fits a larger pattern in how this administration is remaking public health. We've tracked the pieces of it: the CDC's childhood lead-poisoning program eliminated and left defunded, the prevention programs that pay for themselves on the chopping block, and the HHS secretary's own words about disabled Americans in The Productivity Test. Each is defensible on its own; together they raise a fair question about what “health” is being optimized for, and for whom. This diversion is the newest piece of that puzzle.
Questions worth taking seriously
Isn't military and medical research crossing over normal?
Some overlap is old and legitimate — the military has long funded medical work, and biodefense genuinely spans both. The problem here isn't the concept; it's the method. A civilian research budget is being pointed at the Pentagon through a vague, unannounced agreement that appropriators say sidesteps them, to fund work NIH's own leaders said the agency shouldn't do. That combination — secrecy, a decade-long framework, and the contradiction with stated policy — is what makes it a story.
Has the $2 billion actually moved?
No — and we're careful to say so. The NIH director says no funds move this fiscal year, and the agreement is too vague to know the real figure until spending data appears. “Up to $2 billion a year” is a reported ceiling, and roughly a third of NIAID's budget, but it's a projection, not a completed transfer. The concrete thing that exists today is the mechanism and the secrecy around it — not a confirmed payment.
If you are named on this page
If you are named on this page, or are a party materially affected by the claims made here, and you wish to respond, correct the record, or add context, use the Contact page. Responses are published verbatim alongside the original claim, with the sender identified and the date of receipt. The channel stays open for the life of the page.
This site aggregates and grades a record that other outlets and primary sources have already put on the record. Every FACT-graded claim above is sourced to court filings, government reports, sworn whistleblower disclosures, published investigative journalism, or named-source statements. The citations are the accountability mechanism; this section is how you get on the record too.
The record
- Nature — Revealed: inside the US military's plan to tap huge sums from the NIH
- Science — Outrage greets NIH pact that could funnel biodefense research funds to the Pentagon
- Ars Technica — NIH to use part of its budget to pay for Department of Defense research
- Forbes — “Secretive” agreement will divert NIH funds to Pentagon
- CIDRAP (Univ. of Minnesota) — Lawmakers criticize deal that would send NIH funds to the Defense Department
- Inside Higher Ed — Democrats condemn NIH–DOD research agreement (Bhattacharya's defense)
- Sen. Patty Murray — statement on Pentagon efforts to take NIH funding